F
F. Mayr et al.
Paper
Synthesis
1H NMR (400 MHz, CDCl3): δ = 1.50–1.56 (m, 2 H, H-4, H-5), 1.78 (virt.
td, 3J ≅ 3J = 12.8 Hz, 3J = 3.4 Hz, 1 H, H-4), 1.90–1.99 (m, 3 H, H-3, H-5,
H-6), 2.30 (virt. qd, 3J ≅ 3J = 12.4 Hz, 3J = 2.8 Hz, 1 H, H-6), 2.49 (virt.
td, 3J ≅ 3J = 13.7 Hz, 3J = 1.8 Hz, 1 H, H-3), 3.84 (ddd, 3J = 12.3 Hz,
11.3 Hz, 3.7 Hz, 1 H, H-1), 4.55 (ddd, 3J = 12.3 Hz, 11.3 Hz, 4.0 Hz, 1 H,
H-2), 7.17 (s, 1 H, H-4′), 7.54–7.58 (m, 2 H, H-5′, H-7′), 7.69 (ddd,
2-{(1R,2R)-2-(10′-Oxo-10′H-thioxantheno[2′,3′-d]oxazol-2′-yl)-
cyclohexyl}isoindoline-1′′,3′′-dione (12)
The synthesized amide 11 (275 mg, 552 μmol, 1.00 equiv) was dis-
solved in anhyd THF (26 mL). At rt, PPh3 (318 mg, 1.21 mmol,
2.20 equiv) and diisopropyl azodicarboxylate (245 mg, 0.24 mL,
1.21 mmol, 2.20 equiv) were added. The mixture was stirred at rt and
after 4 h, the solvent was evaporated. The crude product was purified
by flash chromatography (4 × 25 cm, CH2Cl2/MeOH 98:2). The desired
product was obtained as a yellow solid (220 mg, 458 μmol, 83%); mp
4
3
4
3J = 8.3, 7.0 Hz, J = 1.6 Hz, 1 H, H-6′), 7.74 (dd, J = 5.5 Hz, J = 3.1 Hz,
2 H, H-5′′, H-6′′), 7.87 (dd, 3J = 5.5 Hz, 4J = 3.1 Hz, 2 H, H-4′′, H-7′′),
8.54–8.60 (m, 1 H, H-8′), 9.20 (s, 1 H, H-1′).
20
13C NMR (100 MHz, CDCl3): δ = 24.6 (t, C-4), 25.4 (t, C-5), 29.5 (t, C-6),
29.6 (t, C-3), 45.4 (d, C-1), 51.1 (d, C-2), 122.0 (d, C-4′), 123.4 (d, 2 C,
C-4′′, C-7′′), 126.3 (d, C-5′), 127.1 (s, C-9a′), 127.8 (d, C-7′), 128.3 (d, C-
1′), 128.5 (s, C-8a′), 130.3 (d, C-8′), 132.0 (s, 2 C, C-3a′′, 7a′′), 133.4 (d,
C-6′), 134.2 (d, 2 C, C-5′′, C-6′′), 135.7 (s, C-4b′), 140.2 (s, C-3′), 144.1
(s, C-4a′), 145.9 (s, C-2′), 168.3 (s, 2 C, C-1′′, C-3′′), 170.9 (s, COO),
177.9 (s, C-9′).
225–227 °C; Rf = 0.50 (CH2Cl2/MeOH 98:2) [UV, KMnO4]; [α]D –152
(c = 1.00, CH2Cl2).
IR (ATR): 3071 (w, CHsp2), 2952 (m, CHsp3), 2921 (m, CHsp3), 2864 (w,
CHsp3), 1764 (m, C=O), 1701 (s, C=O), 1643 (m), 1620 (s), 1435 (m,
CHsp3), 1394 (m), 1373 (m), 1293 (m), 1244 (w), 1155 (w), 1077 (m),
1023 (m), 719 cm–1 (m, CHsp2).
1H NMR (400 MHz, CDCl3): δ = 1.49–1.65 (m, 2 H, H-4, H-5), 1.82–2.07
MS (EI, 70 eV): m/z (%) = 528 (3, [M]+), 273 (29, [C13H7NO4S]+), 256
(m, 4 H, H-3, H-4, H-5, H-6), 2.29–2.45 (m, 2 H, H-3, H-6), 4.12 (ddd,
(100, [C15H14NO3]+), 148 (79, [C8H6NO2]+).
3
3
3J = 12.3 Hz, 11.4 Hz, 3.6 Hz, 1 H, H-2), 4.57 (virt. td, J ≅ J = 11.7 Hz,
3J = 3.8 Hz, 1 H, H-1), 7.44 (ddd, 3J = 8.2 Hz, 6.9 Hz, 4J = 1.3 Hz, 1 H, H-
8′), 7.48–7.52 (m, 2 H, H-4′, H-6′), 7.57 (ddd, 3J = 8.3 Hz, 6.9 Hz,
4J = 1.5 Hz, 1 H, H-7′), 7.64 (dd, 3J = 5.5 Hz, 4J = 3.0 Hz, 2 H, H-5′′, H-6′′),
7.74 (dd, 3J = 5.5 Hz, 4J = 3.0 Hz, 2 H, H-4′′, H-7′′), 8.55 (dd, 3J = 8.2 Hz,
4J = 1.5 Hz, 1 H, H-9′), 8.76 (s, 1 H, H-11′).
HRMS (EI): m/z [M]+ calcd for C28H20N2O7S: 528.0991; found:
528.0995.
(1R,2R)-2-(1′′,3′′-Dioxoisoindolin-2′′-yl)-N-(3′-hydroxy-9′-oxo-9′H-
thioxanthen-2′-yl)cyclohexane-1-carboxamide (11)
13C NMR (101 MHz, CDCl3): δ = 24.8 (t, C-4), 25.5 (t, C-5), 29.9 (t, C-3),
30.7 (t, C-6), 40.0 (d, C-2), 52.5 (d, C-1), 106.3 (d, C-4′), 122.0 (d, C-
11′), 123.4 (d, 2 C, C-4′′, C-7′′), 125.7 (d, C-6′), 126.4 (d, C-8′), 126.5 (s,
C-4a′), 128.7 (s, C-9a′), 130.0 (d, C-9′), 131.8 (s, 2 C, C-3a′′, C-7a′′),
132.3 (d, C-7′), 134.1 (d, 2 C, C-5′′, C-6′′), 134.2 (s, C-10a′), 137.0 (s, C-
5a′), 141.0 (s, C-3a′), 153.0 (s, C-11a′), 168.2 (s, 2 C, C-1′′, C-3′′), 168.9
(s, C-2′), 179.8 (s, C-10′).
Ester 10 (406 mg, 768 μmol, 1.00 equiv) was dissolved in THF (27 mL)
and H2O (27 mL) was added. To this solution In (441 mg, 3.84 mmol,
5.00 equiv) and concd HCl (0.75 mL) were added. The mixture was
stirred at 80 °C for 18 h. After this time, the solution was cooled to rt
and CH2Cl2 (50 mL) was added. The mixture was filtered over Celite
and washed with aq NaHCO3 (100 mL). The aqueous layer was ex-
tracted with CH2Cl2 (3 × 100 mL). The combined organic layers were
dried (Na2SO4), filtered, and the solvent was removed under reduced
pressure. Purification by flash chromatography (4 × 20 cm, CH2Cl2/
MeOH 95:5) furnished the title compound as an orange-colored solid
(310 mg, 622 μmol, 81%); mp 150–154 °C; Rf = 0.51 (CH2Cl2/MeOH
95:5) [UV, KMnO4]; [α]D20 +46 (c = 1.00, CH2Cl2).
HRMS (ESI): m/z [M + H]+ calcd for C28H20N2O4S: 481.1217; found:
481.1217.
1-[3′′,5′′-Bis(trifluoromethyl)phenyl]-3-{(1R,2R)-2-(10′-oxo-10′H-
thioxantheno[2′,3′-d]oxazol-2′-yl)cyclohexyl}thiourea (1)
IR (ATR): 3296 (w, NH), 3066 (w, OH), 2931 (m, CHsp3), 2857 (m,
CHsp3), 1766 (w), 1700 (s, C=O), 1588 (m, C=Csp2), 1517 (m, C=Csp2),
1438 (m, CHsp3), 1369 (m), 1294 (w), 1262 (w), 1077 (m), 717 cm–1
(m, CHsp2).
Oxazole 12 (70.0 mg, 146 μmol, 1.00 equiv) was dissolved in anhyd
MeOH (13 mL). Hydrazine hydrate (364 mg, 0.36 mL, 7.29 mmol,
50.0 equiv) was added and the mixture was stirred at rt for 24 h.
Upon removal of the solvent, the residue was dissolved in CH2Cl2 and
filtered over SiO2 (1 × 2 cm, CH2Cl2/MeOH 95:5). After evaporation of
the solvent, the crude material was used in the next step without fur-
ther purification. The crude material was dissolved in anhyd THF
(10 mL) and 3,5-bis(trifluoromethyl)phenyl isothiocyanate (83.1 mg,
0.06 mL, 307 μmol, 2.10 equiv) was added. The reaction mixture was
stirred at rt and after 18 h, the solvent was evaporated. Purification by
flash chromatography (2 × 7 cm, CH2Cl2/MeOH 99:1) afforded the de-
sired thiourea as a yellow solid (29.0 mg, 46.7 μmol, 32% over two
steps); mp 124–126 °C; Rf = 0.20 (CH2Cl2/MeOH 99:1) [UV, KMnO4];
[α]D20 +80 (c = 1.00, CH2Cl2).
1H NMR (400 MHz, CDCl3): δ = 1.00–1.17 (m, 1 H, H-5), 1.42–1.54 (m,
1 H, H-4), 1.63–1.82 (m, 4 H, H-3, H-4, H-5, H-6), 2.00 (virt. dq,
3J = 12.7 Hz, 3J ≅ 3J = 3.6 Hz, 1 H, H-3), 2.06–2.18 (m, 1 H, H-6), 3.82
(virt. td, 3J ≅ 3J = 11.8 Hz, 3J = 3.7 Hz, 1 H, H-1), 4.53 (virt. td, 3J ≅
3
3J = 11.8 Hz, J = 4.0 Hz, 1 H, H-2), 6.99 (s, 1 H, H-4′), 7.44–7.48 (m, 2
H, H-7′, H-5′), 7.53–7.56 (m,
1
H, H-6′), 7.59 (dd, 3J = 5.5 Hz,
4J = 3.0 Hz, 2 H, H-5′′, H-6′′), 7.73 (dd, 3J = 5.5 Hz, 4J = 3.0 Hz, 2 H, H-4′′,
H-7′′), 8.47 (s, 1 H, H-1′), 8.61 (dd, 3J = 8.4 Hz, 4J = 1.6 Hz, 1 H, H-8′),
9.33 (s, 1 H, NH), 10.81 (s, 1 H, OH).
13C NMR (101 MHz, CDCl3): δ = 24.7 (t, C-5), 25.2 (t, C-4), 29.8 (t, C-3),
30.9 (t, C-6), 47.4 (d, C-1), 51.8 (d, C-2), 114.6 (d, C-4′), 121.9 (s, C-4a′),
123.4 (d, 2 C, C-4′′, C-7′′), 123.7 (d, C-1′), 126.0 (d, C-7′), 126.4 (d, C-
5′), 126.9 (s, C-3′), 128.6 (s, C-8a′), 130.0 (d, C-8′), 131.8 (s, 2 C, C-3a′′,
C-7a′′), 132.2 (d, C-6′), 134.1 (d, 2 C, C-5′′, C-6′′), 136.6 (s, C-9a′), 137.5
(s, C-4b′), 153.8 (s, C-2′), 168.5 (s, 2 C, C-1′′, C-3′′), 175.2 (s, CON),
179.3 (s, C-9′).
IR (ATR): 3327 (w, NH), 2956 (w, CHsp3), 2929 (w, CHsp3), 2852 (w,
CHsp3), 1701 (m, C=O), 1625 (m, C=Csp2), 1438 (m, CHsp3), 1277 (m),
1028 (m), 910 (m), 749 cm–1 (m, CHsp2).
1H NMR (400 MHz, CDCl3): δ = 1.55–1.79 (m, 4 H, H-4, H-5), 1.93–2.00
(m, 2 H, H-3, H-6), 2.08–2.17 (m, 1 H, H-6), 2.37–2.41 (m, 1 H, H-3),
3.73 (br s 1 H, H-2), 4.96–5.16 (m, 1 H, H-1), 7.41–7.68 (m, 5 H, H-4′,
H-6′, H-7′, H-8′, H-4′′), 7.95 (s, 2 H, H-2′′), 8.15 (br s, 1 H, NH), 8.50 (d,
3J = 8.1 Hz, 1 H, H-9′), 8.68 (s, 1 H, H-11′), 9.01 (br s, 1 H, NH).
MS (EI, 70 eV): m/z (%) = 498 (1, [M]+), 480 (10 [M – H2O]+), 333 (100,
[C20H15NO2S]+), 280 (10), 170 (3), 71 (10).
13C NMR (101 MHz, CDCl3): δ = 21.2 (t, C-4*), 22.0 (t, C-5*), 28.3 (t, C-
6), 39.3 (t, C-3), 54.0 (d, C-2), 60.6 (d, C-1), 106.8 (d, C-4′), 118.7 (d, C-
4′′), 119.0 (s, C-1′′), 121.3 (d, C-11′), 122.5 (q, JC,F = 165 Hz, 2 C, CF3),
HRMS (EI): m/z [M]+ calcd for C28H22N2O5S: 498.1249; found:
498.1248.
1
Georg Thieme Verlag Stuttgart · New York — Synthesis 2017, 49, A–M